Skip to main content
  • Regulatory Update

US FDA Transitions COVID-19 Guidance Documents for the End of Public Health Emergency

Drawing of box with FDA logo on it

March 27, 2023

The FDA issued a notice identifying how the agency plans to transition the guidance documents related to COVID-19 once the public health emergency (PHE) ends. Notably, on medical devices, the guidance Policy for Coronavirus Disease-2019 Tests (Revised) and Policy for Evaluating Impact of Viral Mutations on COVID-19 Tests are identified to remain in effect indefinitely. Most device-specific guidances will remain in effect 180 days after the PHE ends for transition.

Emergo by UL will post updates as they become available.


Get connected with our sales team

Thanks for your interest in UL's products and services. Let's collect some information so we can connect you with the right person.

Please wait…